<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="23" left="55" width="517" height="33" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="77" left="138" width="53" height="12" font="1">Sep 12, 2011</text>
<text top="359" left="94" width="338" height="12" font="1">Rabbit polyclonal IgG, epitope mapping at the C-terminus of YY1 of human origin</text>
<text top="485" left="150" width="31" height="12" font="1">Human</text>
<text top="521" left="178" width="53" height="12" font="2">Western Blot</text>
<text top="134" left="326" width="102" height="12" font="1">fpauli@hudsonalpha.org</text>
<text top="134" left="83" width="61" height="12" font="1">Florencia Pauli</text>
<text top="215" left="121" width="56" height="12" font="1">YY1_(SC-281)</text>
<text top="215" left="339" width="16" height="12" font="1">YY1</text>
<text top="170" left="230" width="25" height="12" font="1">Myers</text>
<text top="255" left="239" width="107" height="12" font="1">Santa Cruz Biotechnology</text>
<text top="485" left="361" width="27" height="12" font="1">Rabbit</text>
<text top="300" left="395" width="56" height="12" font="1">B1010, F2810</text>
<text top="300" left="215" width="27" height="12" font="1">sc-281</text>
<text top="521" left="395" width="54" height="12" font="2">IP-Mass Spec</text>
<text top="561" left="356" width="43" height="12" font="2">Polyclonal</text>
<text top="413" left="94" width="420" height="12" font="1">YY1 is a ubiquitously distributed transcription factor belonging to the GLI-Kruppel class of zinc finger </text>
<text top="425" left="94" width="386" height="12" font="1">proteins. The protein is involved in repressing and activating a diverse number of promoters. </text>
<text top="437" left="94" width="2" height="12" font="1"> </text>
<text top="449" left="94" width="116" height="12" font="1">Entrez gene ID 7528; 60 kDa</text>
<text top="599" left="238" width="149" height="12" font="1">http://www.scbt.com/product.php?</text>
<text top="611" left="238" width="63" height="12" font="1">datasheet=281</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="80" left="125" width="95" height="12" font="1">Western blot protocol: </text>
<text top="92" left="125" width="428" height="12" font="1">Whole cell lysate was immunoprecipitated using primary antibody, and the IP fraction was loaded on a </text>
<text top="104" left="125" width="422" height="12" font="1">12% acrylamide gel and separated with a Bio-Rad PROTEAN II xi system. After separation, the samples </text>
<text top="116" left="125" width="422" height="12" font="1">were transferred to a nitrocellulose membrane with an Invitrogen iBlot system.  Blotting with primary </text>
<text top="128" left="125" width="422" height="12" font="1">(same as that used for IP) and secondary HRP-conjugated antibodies was performed on an Invitrogen </text>
<text top="140" left="125" width="414" height="12" font="1">BenchPro 4100 system. Visualization was achieved using SuperSignal West Femto solution (Thermo </text>
<text top="152" left="125" width="47" height="12" font="1">Scientific).  </text>
<text top="164" left="125" width="2" height="12" font="1"> </text>
<text top="176" left="125" width="346" height="12" font="1">Results: Band of expected size visualized, representing strongest signal in the lane.  </text>
<text top="188" left="125" width="2" height="12" font="1"> </text>
<text top="200" left="125" width="420" height="12" font="1">Figure legend: IP-western with sc-281 in whole cell lysate (WCL) of HepG2, HeLa, GM12878 and K562; </text>
<text top="212" left="125" width="190" height="12" font="1">PM=protein marker. YY1 bands are indicated. </text>
</page>
<page number="3" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="99" left="130" width="144" height="12" font="1">IP followed by mass spectrometry: </text>
<text top="111" left="130" width="419" height="12" font="1">Briefly, K562 whole cell lysates were immunoprecipitated using primary antibody, and the IP fraction </text>
<text top="123" left="130" width="402" height="12" font="1">was loaded on a 12% acrylamide gel and separated with a Bio-Rad PROTEAN II xi system. Gel was </text>
<text top="135" left="130" width="417" height="12" font="1">stained with Coomassie Blue in order to visualize marker bands. Gel fragments corresponding to the </text>
<text top="147" left="130" width="420" height="12" font="1">bands indicated above in the western blot image were excised and sent to the University of Alabama </text>
<text top="159" left="130" width="423" height="12" font="1">at Birmingham Cancer Center Mass Spectrometry/Proteomics Shared Facility. There the samples were </text>
<text top="171" left="130" width="423" height="12" font="1">run on an LTQ XL Linear Ion Trap Mass Spectrometer by LC-ESI-MS/MS. Peptides were identified using </text>
<text top="183" left="130" width="355" height="12" font="1">SEQUEST tandem mass spectra analysis, with probability based matching at p &lt; 0.05.  </text>
<text top="195" left="130" width="2" height="12" font="1"> </text>
<text top="207" left="130" width="268" height="12" font="1">As per ENCODE data standards, all SEQUEST results are attached </text>
<text top="219" left="130" width="401" height="12" font="1">(ENCODE_HAIB_YY1_sc281_09122011_MassSpec.pdf), including common contaminants. Target </text>
<text top="231" left="130" width="173" height="12" font="1">protein is listed as hit 17 in ~60 kDa band.</text>
<text top="695" left="268" width="68" height="12" font="1">Submit by Email</text>
</page>
<page number="4" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="3" size="11" family="Times" color="#000000"/>
	<fontspec id="4" size="10" family="Times" color="#000000"/>
	<fontspec id="5" size="5" family="Times" color="#000000"/>
	<fontspec id="6" size="5" family="Times" color="#000000"/>
<text top="72" left="59" width="282" height="16" font="3"><b>Validation 2: Mass Spectrometry Analysis </b></text>
<text top="98" left="59" width="503" height="13" font="4">ENCODE  data  standards  recognizes  various  methodologies  for  secondary  validation  of </text>
<text top="112" left="59" width="503" height="13" font="4">antibodies.  Among  these  methodologies  is  immunoprecipitation  followed  by  mass </text>
<text top="126" left="59" width="503" height="13" font="4">spectrometry  analysis.  Briefly,  K562  whole  cell  lysates  were  immunoprecipitated  using </text>
<text top="140" left="59" width="503" height="13" font="4">primary antibody, and the IP fraction was loaded on a 12% acrylamide gel and separated with </text>
<text top="154" left="59" width="503" height="13" font="4">a Bio-Rad PROTEAN II xi system. Gel was stained with Coomasie Blue in order to visualize </text>
<text top="167" left="59" width="503" height="13" font="4">marker bands. A gel fragment corresponding to the band indicated above in the western blot </text>
<text top="181" left="59" width="503" height="13" font="4">image was excised and sent to the University of Alabama at Birmingham Cancer Center Mass </text>
<text top="195" left="59" width="503" height="13" font="4">Spectrometry/Proteomics Shared Facility. There the sample was run on an LTQ XL Linear Ion </text>
<text top="209" left="59" width="503" height="13" font="4">Trap  Mass  Spectrometer  with  alternating  collision-induced  dissociation  and  electron-transfer </text>
<text top="223" left="59" width="503" height="13" font="4">dissociation. Peptides were identified using MASCOT (Matrix Science), with probability based </text>
<text top="236" left="59" width="503" height="13" font="4">matching  at  p  &lt;  0.05.  Subsequent  analysis  was  performed  in  Scaffold  (Proteome  Software, </text>
<text top="250" left="59" width="503" height="13" font="4">Inc.)  at  0.0%  protein  FDR  and  1.7%  peptide  FDR.  As  per  ENCODE  data  standards,  all </text>
<text top="264" left="59" width="503" height="13" font="4">Scaffold  results  are  listed  below,  including  common  contaminants.  Target  protein  is </text>
<text top="278" left="59" width="127" height="13" font="4">highlighted in bold font. </text>
<text top="302" left="59" width="3" height="13" font="4"> </text>
<text top="325" left="72" width="9" height="9" font="5">1. </text>
<text top="325" left="90" width="282" height="9" font="5">T-complex protein 1 subunit alpha n=2 Tax=Homininae RepID=TCPA_HUMAN </text>
<text top="325" left="396" width="30" height="9" font="5">P17987 </text>
<text top="339" left="72" width="9" height="9" font="5">2. </text>
<text top="339" left="90" width="282" height="9" font="5">Pyruvate kinase isozymes M1/M2 n=2 Tax=Homininae RepID=KPYM_HUMAN </text>
<text top="339" left="396" width="30" height="9" font="5">P14618 </text>
<text top="353" left="72" width="9" height="9" font="5">3. </text>
<text top="353" left="90" width="206" height="9" font="5">PIG48 n=1 Tax=Homo sapiens RepID=Q2TU64_HUMAN </text>
<text top="353" left="324" width="32" height="9" font="5">Q2TU64 </text>
<text top="367" left="72" width="9" height="9" font="5">4. </text>
<text top="367" left="90" width="360" height="9" font="5">Mitochondrial heat shock 60kD protein 1 variant 1 n=1 Tax=Homo sapiens RepID=B3GQS7_HUMAN </text>
<text top="367" left="468" width="51" height="9" font="5">B3GQS7 (+1) </text>
<text top="380" left="72" width="9" height="9" font="5">5. </text>
<text top="380" left="90" width="470" height="9" font="5">cDNA  FLJ30049  fis,  clone  ADRGL1000033,  highly  similar  to  26S  proteasome  non-ATPase  regulatory  subunit  3  n=1  Tax=Homo </text>
<text top="394" left="90" width="176" height="9" font="5">sapiens RepID=B3KNN7_HUMAN  B3KNN7 (+4) </text>
<text top="408" left="72" width="9" height="9" font="5">6. </text>
<text top="408" left="90" width="470" height="9" font="5">cDNA,  FLJ93545,  highly  similar  to  Homo  sapiens  5-aminoimidazole-4-carboxamide  ribonucleotide  formyltransferase/IMP </text>
<text top="422" left="90" width="289" height="9" font="5">cyclohydrolase (ATIC), mRNA n=1 Tax=Homo sapiens RepID=B2R7P8_HUMAN </text>
<text top="422" left="396" width="49" height="9" font="5">B2R7P8 (+1) </text>
<text top="436" left="72" width="9" height="9" font="5">7. </text>
<text top="436" left="90" width="399" height="9" font="5">cDNA FLJ54957, highly similar to Transketolase (EC 2.2.1.1) n=1 Tax=Homo sapiens RepID=B4DE31_HUMAN </text>
<text top="436" left="504" width="49" height="9" font="5">B4DE31 (+3) </text>
<text top="449" left="72" width="9" height="9" font="5">8. </text>
<text top="449" left="90" width="470" height="9" font="5">cDNA  FLJ59339,  highly  similar  to  Probable  ATP-dependent  RNA  helicase  DDX5  (EC  3.6.1.-)  n=1  Tax=Homo  sapiens </text>
<text top="463" left="90" width="95" height="9" font="5">RepID=B4DLW8_HUMAN </text>
<text top="463" left="216" width="51" height="9" font="5">B4DLW8 (+1) </text>
<text top="477" left="72" width="9" height="9" font="5">9. </text>
<text top="477" left="90" width="281" height="9" font="5">T-complex protein 1 subunit theta n=2 Tax=Hominidae RepID=TCPQ_HUMAN </text>
<text top="477" left="396" width="46" height="9" font="5">P50990 (+2) </text>
<text top="491" left="72" width="332" height="9" font="5">10.  Heterogeneous nuclear ribonucleoprotein K n=4 Tax=Eutheria RepID=HNRPK_HUMAN </text>
<text top="491" left="432" width="46" height="9" font="5">P61978 (+2) </text>
<text top="505" left="72" width="488" height="9" font="5">11.  cDNA, FLJ94440, highly similar to Homo sapiens chaperonin containing TCP1, subunit 6A (zeta 1)(CCT6A), mRNA n=1 Tax=Homo </text>
<text top="518" left="90" width="175" height="9" font="5">sapiens RepID=B2R9K8_HUMAN  B2R9K8 (+2) </text>
<text top="532" left="72" width="486" height="9" font="5">12.  cDNA  FLJ53116,  highly  similar  to  T-complex  protein  1  subunit  epsilon  n=1  Tax=Homo  sapiens  RepID=B4DZT5_HUMAN</text>
<text top="546" left="90" width="2" height="9" font="5"> </text>
<text top="546" left="108" width="49" height="9" font="5">B4DZT5 (+2) </text>
<text top="560" left="72" width="327" height="9" font="5">13.  Tyrosyl-tRNA synthetase, cytoplasmic n=2 Tax=Homo sapiens RepID=SYYC_HUMAN </text>
<text top="560" left="432" width="30" height="9" font="5">P54577 </text>
<text top="574" left="72" width="488" height="9" font="5">14.  cDNA  FLJ76817,  highly  similar  to  Homo  sapiens  non-POU  domain  containing,  octamer-binding  (NONO),  mRNA  n=1  Tax=Homo </text>
<text top="587" left="90" width="173" height="9" font="5">sapiens RepID=A8K525_HUMAN  A8K525 (+2) </text>
<text top="601" left="72" width="333" height="9" font="5">15.  Ribosomal L1 domain-containing protein 1 n=3 Tax=Hominidae RepID=RL1D1_HUMAN </text>
<text top="601" left="432" width="47" height="9" font="5">O76021 (+2) </text>
<text top="615" left="72" width="228" height="9" font="5">16.  Serum albumin n=1 Tax=Bos taurus RepID=ALBU_BOVIN </text>
<text top="615" left="324" width="30" height="9" font="5">P02769 </text>
<text top="629" left="72" width="340" height="9" font="6"><b>17.  Transcriptional repressor protein YY1 n=1 Tax=Homo sapiens RepID=TYY1_HUMAN </b></text>
<text top="629" left="432" width="30" height="9" font="6"><b>P25490 </b></text>
<text top="643" left="72" width="366" height="9" font="5">18.  ATP-binding cassette sub-family E member 1 n=4 Tax=Euarchontoglires RepID=ABCE1_HUMAN </text>
<text top="643" left="468" width="30" height="9" font="5">P61221 </text>
<text top="656" left="72" width="373" height="9" font="5">19.  Insulin-like growth factor 2 mRNA-binding protein 1 n=1 Tax=Homo sapiens RepID=IF2B1_HUMAN </text>
<text top="656" left="468" width="30" height="9" font="5">Q9NZI8 </text>
<text top="670" left="72" width="331" height="9" font="5">20.  Ubiquitin carboxyl-terminal hydrolase n=1 Tax=Homo sapiens RepID=A6NJA2_HUMAN </text>
<text top="670" left="432" width="48" height="9" font="5">A6NJA2 (+3) </text>
<text top="684" left="72" width="488" height="9" font="5">21.  cDNA  FLJ75056,  highly  similar  to  Homo  sapiens  phosphatidylinositol  binding  clathrin  assembly  protein  (PICALM),  mRNA  n=1 </text>
<text top="698" left="90" width="165" height="9" font="5">Tax=Homo sapiens RepID=A8K5U9_HUMAN </text>
<text top="698" left="288" width="49" height="9" font="5">A8K5U9 (+8) </text>
</page>
<page number="5" position="absolute" top="0" left="0" height="792" width="612">
<text top="72" left="72" width="488" height="9" font="5">22.  cDNA FLJ75460, highly similar to Homo sapiens phenylalanine-tRNA synthetase-like, beta subunit, mRNA n=1 Tax=Homo sapiens </text>
<text top="86" left="90" width="137" height="9" font="5">RepID=A8K666_HUMAN A8K666 (+3) </text>
<text top="100" left="72" width="488" height="9" font="5">23.  cDNA  FLJ51387,  highly  similar  to  Asparagine  synthetase  (glutamine-hydrolyzing)  (EC  6.3.5.4)  n=1  Tax=Homo  sapiens </text>
<text top="114" left="90" width="93" height="9" font="5">RepID=B4DY32_HUMAN </text>
<text top="114" left="216" width="49" height="9" font="5">B4DY32 (+1) </text>
<text top="127" left="72" width="417" height="9" font="5">24.  Chaperonin containing TCP1, subunit 7 (Eta), isoform CRA_c n=1 Tax=Homo sapiens RepID=B7Z4T9_HUMAN </text>
<text top="127" left="504" width="47" height="9" font="5">B7Z4T9 (+4) </text>
<text top="141" left="72" width="357" height="9" font="5">25.  AAA domain containing 3A protein n=2 Tax=Homo sapiens RepID=D2K8Q1_HUMAN D2K8Q1 </text>
<text top="155" left="72" width="337" height="9" font="5">26.  Guanine nucleotide-binding protein-like 3 n=2 Tax=Homo sapiens RepID=GNL3_HUMAN </text>
<text top="155" left="432" width="33" height="9" font="5">Q9BVP2 </text>
<text top="169" left="72" width="269" height="9" font="5">27.  Nucleolar protein 58 n=1 Tax=Homo sapiens RepID=NOP58_HUMAN </text>
<text top="169" left="360" width="32" height="9" font="5">Q9Y2X3 </text>
<text top="183" left="72" width="345" height="9" font="5">28.  Putative uncharacterized protein EIF3D n=1 Tax=Homo sapiens RepID=A8MWD3_HUMAN </text>
<text top="183" left="432" width="53" height="9" font="5">A8MWD3 (+3) </text>
<text top="196" left="72" width="488" height="9" font="5">29.  cDNA FLJ31567 fis, clone NT2RI2001540, highly similar to Eukaryotic translation initiation factor 3 subunit 6-interacting protein n=1 </text>
<text top="210" left="90" width="165" height="9" font="5">Tax=Homo sapiens RepID=B3KPB9_HUMAN </text>
<text top="210" left="288" width="49" height="9" font="5">B3KPB9 (+3) </text>
<text top="224" left="72" width="260" height="9" font="5">30.  Pyruvate kinase n=1 Tax=Homo sapiens RepID=B4DPM0_HUMAN </text>
<text top="224" left="360" width="51" height="9" font="5">B4DPM0 (+6) </text>
<text top="238" left="72" width="301" height="9" font="5">31.  Heat shock cognate 71 kDa protein n=8 Tax=Eutheria RepID=HSP7C_HUMAN </text>
<text top="238" left="396" width="30" height="9" font="5">P11142 </text>
<text top="261" left="72" width="3" height="14" font="4">	  </text>
</page>
</pdf2xml>
